OTCQB: PHRRF | CSE: PHRM
PharmaTher Holdings Ltd. Ketamine
  • HOME
  • COMPANY
  • PORTFOLIO
    • Microneedle Patch
    • KETAMINE
    • Peptides
    • SAIRIYO
  • INVESTORS
  • NEWS
  • HOME
  • COMPANY
  • PORTFOLIO
    • Microneedle Patch
    • KETAMINE
    • Peptides
    • SAIRIYO
  • INVESTORS
  • NEWS

Press Releases

10/15/2025

PharmaTher Announces KetAImine™ — AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings

 

Read More

10/8/2025

PharmaTher Provides Update on Ketamine Program for LID-Parkinson’s Disease

 

Read More

10/2/2025

PharmaTher Provides Corporate Update on Ketamine Development and Commercial Strategy

 

Read More

10/1/2025

PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate Over US$25 Million in Milestone and Profit-Sharing Payments

 

Read More

8/27/2025

PharmaTher Advances Ketamine Patch as Non-Opioid Pain Relief Solution Leveraging FDA Approved IV Ketamine, Aligned with FDA’s CNPV National Priority Initiative

 

Read More

8/26/2025

PharmaTher Provides Corporate Update Following FDA Approval of Ketamine

 

Read More

8/14/2025

PharmaTher Founder and CEO Issues Letter to Shareholders following the FDA Approval of Ketamine

 

Read More

8/11/2025

PharmaTher Announces FDA Approval of Ketamine

 

Read More

7/2/2025

PharmaTher Announces Path to Ketamine Commercialization with No Planned Financing, Confirms FDA Approval Goal Date of August 9th, 2025 for Ketamine

 

Read More

6/24/2025

PharmaTher Secures Key US Patent for Ketamine in Amyotrophic Lateral Sclerosis (ALS), Bolstering its Orphan Drug Designated Program and Targeting a Billion Dollar Market

 

Read More
Previous
Forward

    Archives

    March 2026
    February 2026
    January 2026
    December 2025
    November 2025
    October 2025
    August 2025
    July 2025
    June 2025
    May 2025
    March 2025
    February 2025
    January 2025
    November 2024
    October 2024
    September 2024
    August 2024
    May 2024
    April 2024
    February 2024
    January 2024
    September 2023
    July 2023
    June 2023
    May 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020

    Categories

    All

    RSS Feed

Psychedelic Pharmaceuticals
Contact Us
© COPYRIGHT 2026.  PharmaTher Holdings Ltd.   ALL RIGHTS RESERVED.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."